Market Research Logo

Global Companion Animal Specialty Drugs Market 2017-2021

Global Companion Animal Specialty Drugs Market 2017-2021

About Companion Animal Specialty Drugs

Companion animals are becoming a part of urban population. The factors that have contributed to increased companion animal ownership includes nuclear families and the growing geriatric population living independently. This increasing pet adoption is essentially driving the demand for companion animal specialty drugs, because of the growing prevalence of various diseases and awareness toward pet nutrition.

Technavio’s analysts forecast the global companion animal specialty drugs market to grow at a CAGR of 4.99% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global companion animal specialty drugs market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Companion Animal Specialty Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bayer
  • Elanco
  • Merial
  • Zoetis
Other prominent vendors
  • Aratana therapeutics
  • Beaphar
  • Henry Schein
  • Mars
  • The J.M Smucker Company
Market driver
  • Increase in Pet humanization
  • For a full, detailed list, view our report
Market challenge
  • Patent expiry
  • For a full, detailed list, view our report
Market trend
  • Enhanced product offerings
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Companion Animal Specialty Drugs Market 2017-2021

Technavio recognizes the following companies as the key players in the global companion animal specialty drugs market: Bayer, Elanco, Merial, and Zoetis.

Other Prominent Vendors in the market are: Aratana therapeutics, Beaphar, Henry Schein, Mars, and The J.M Smucker Company.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is enhanced product offerings. The companion animal specialty drug market is witnessing a significant increase in product portfolio. The focus on product differentiation through novel delivery technology is increasing. This differentiation helps to enhance compliance of the companion animal, and thus, results in higher efficacy.”

According to the report, one driver in the market is increase in Pet humanization. The pets are increasingly being treated as a member of the family. Therefore, the focus on the wellbeing of the companion animals is increasing significantly. The owners of pets are looking for good healthcare products to lengthen the healthy lifespan of their animal companions. This is evident in both emerging as well as developed markets. The population that owns pets is also increasing. As per the CDC, 40 million households in the US own a cat as a companion animal. Globally, the owners of pets are ensuring that the quality of ingredients and manufacturing standards of their companion animal products are as good as products intended for humans.

Further, the report states that one challenge in the market is patent expiry. In the coming years, many companion animal specialty drugs will lose their patents. The decline in prices due to patent expiries will negatively impact the global companion animal specialty drugs market. For example, in 2018, the process patent for Revolution expires and the patent for the active ingredient, Selamectin formulation, expires in 2019. Between 2022 to 2024, another formulation patent related to the product line of Convenia will expire. The process of drug approval for veterinary use is far more stringent than the drugs intended for humans, resulting in lesser rates of drug approvals for animals, which further aggravates concerns over the high rate of patent expiries described above.

Companies Mentioned

Bayer, Elanco, Merial, Zoetis, Aratana therapeutics, Beaphar, Henry Schein, Mars, and The J.M Smucker Company.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
  • Overview
    • Table Health hazards in companion animals
    • One Health Concept
  • Market Landscape
    • Market overview
      • Table Global companion animal specialty drugs market by product type
  • Market sizing
    • Market size and forecast 2016-2021
      • Table Global companion animal specialty drugs market 2016-2021 ($ millions)
      • Table Global companion animal specialty drugs market: Year-over-year growth 2017-2021 (%)
  • Five forces analysis
    • Table Five forces analysis
  • Market segmentation by product type
    • Segmentation by product type
      • Table Global companion animal specialty drugs market by product type 2016-2021 (%)
    • Comparison by product type
      • Table Global companion animal specialty drugs comparison by product type
    • Global companion animal vaccines market
      • Table Global companion animal vaccines market 2016-2021 ($ millions)
      • Table Global companion animal vaccines market: Year-over-year growth 2017-2021 (%)
    • Global companion animal antibiotics market
      • Table Global companion animal antibiotics market 2016-2021 ($ millions)
      • Table Global companion animal antibiotics market: Year-over-year growth 2017-2021 (%)
    • Global companion animal feed additives market
      • Table Global companion animal feed additives market 2016-2021 ($ millions)
      • Table Global companion animal feed additives market: Year-over-year growth 2017-2021 (%)
    • Global companion animal parasiticides market
      • Table Global companion animal parasiticides market 2016-2021 ($ millions)
      • Table Global companion animal parasiticides market: Year-over-year growth 2017-2021 (%)
    • Global companion animal others drugs market
      • Table Global companion animal others market 2016-2021 ($ millions)
      • Table Global companion animal others market: Year-over-year growth 2017-2021 (%)
    • Market opportunity by product type
      • Table Market opportunity by product type
  • Market segmentation by distribution channel
    • Veterinary hospitals
    • Pet care clinics
    • Pharmacy stores
  • Regional landscape
    • Geographical segmentation
      • Table Global companion animal specialty drugs by geography 2016-2021 (% share)
    • Regional comparison
      • Table Regional comparison
    • Companion animal specialty drugs market in Americas
      • Table Companion animal specialty drugs market in Americas 2016-2021 ($ millions)
      • Table Companion animal specialty drugs market in Americas: Year-over-year growth 2017-2021
    • Companion animal specialty drugs market in EMEA
      • Table Companion animal specialty drugs market in EMEA 2016-2021 ($ millions)
      • Table Companion animal specialty drugs market in EMEA: Year-over-year growth 2017-2021
    • Companion animal specialty drugs market in APAC
      • Table Companion animal specialty drugs market in APAC 2016-2021 ($ millions)
      • Table Companion animal specialty drugs market in APAC: Year-over-year growth 2017-2021
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Enhanced product offerings
    • Increase in M&A
    • Rising obesity in pets
  • Vendor landscape
  • Vendor analysis
    • Vendor overview
    • Bayer
      • Table Bayer: Key highlights
      • Table Bayer: Strength assessment
      • Table Bayer: Strategy assessment
      • Table Bayer: Opportunity assessment
    • Elanco
      • Table Elanco Pharmaceuticals: Key highlights
      • Table Elanco: Strength assessment
      • Table Elanco: Strategy assessment
      • Table Elanco: Opportunity assessment
    • Merial
      • Table Merial: Key highlights
      • Table Merial: Strength assessment
      • Table Merial: Strategy assessment
      • Table Merial: Opportunity assessment
    • Zoetis
      • Table Zoetis: Key highlights
      • Table Zoetis: Strength assessment
      • Table Zoetis: Strategy assessment
      • Table Zoetis: Opportunity assessment
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report